Year: 2020
-
Recent books by Peabody faculty
Books on specific strategies and practices for using digital tools to reduce inequities in educational opportunities and improve student outcomes and the core ingredients of leadership have been recently published by Vanderbilt faculty. Read MoreOct 2, 2020
-
Trailblazing alumna Dorothy Phillips discusses her career as a chemist, importance of diversity in the physical sciences
Dorothy J. Wingfield Phillips, BA’67, the first African American woman to receive an undergraduate degree from Vanderbilt and a member of the inaugural class of Vanderbilt Trailblazers, recently was interviewed by the American Chemical Society about her career as a chemist and the importance of making the physical sciences more inclusive for women and underrepresented minorities. Read MoreOct 2, 2020
-
NSF seed grant supports biomanufacturing of new drug delivery technologies
Vanderbilt researchers awarded one of NSF’s 24 new projects to drive future manufacturing One of the challenges of drug delivery systems is to optimize their targeting properties so therapeutic compounds used in smaller amounts reach only a specific area of the body and result in little or no side effects. The ability to engineer the... Read MoreOct 2, 2020
-
Vanderbilt and Australian researchers collaborate to solve decades-long debate about decision-making
Psychology researchers develop new methodologies and representations of how people react to incoming information to better understand complex decision-making. Read MoreOct 1, 2020
-
Pinpointing brain changes in psychosis
Specific regions of the thalamus — a central brain region — are smaller in adults with psychotic disorders and youth at risk for psychotic disorders and are associated with cognitive impairment. Read MoreOct 1, 2020
-
Genes spell penicillin allergy risk
Studies using large DNA biobanks revealed genetic variants associated with penicillin allergy, the most common type of drug-induced allergic reaction. Read MoreOct 1, 2020
-
Vanderbilt biologists test evolutionary theories with novel empirical study of ‘cheater’ mitochondria
Studying “cheater” and “cooperative” mitochondria under environmental pressure delivers solid evolutionary conclusions in a longstanding theoretical field. Read MoreSep 25, 2020
-
Cohen Fund bolsters Siciliano’s memory research
Cody Siciliano, PhD, assistant professor of Pharmacology in the Vanderbilt University School of Medicine, has been selected to receive a one-year, $100,000 research award from the Stanley Cohen Innovation Fund to support his studies of the neural substrates of memory. Read MoreSep 24, 2020
-
$100 million ‘Destination Vanderbilt’ initiative launched to recruit top faculty, address essential challenges
Vanderbilt University today launched Destination Vanderbilt, a $100 million university excellence initiative to recruit new faculty. Over the next two to four years, the university will leverage the investment to recruit approximately 60 faculty who are leaders and rising stars in their fields. Read MoreSep 23, 2020
-
How to spot misinformation—and what to do about it: Expert advice from psychology professor Lisa Fazio
Lisa Fazio, assistant professor of psychology and human development at Peabody College, shares a few tips on how to avoid knowledge neglect and spreading misinformation. Read MoreSep 22, 2020
-
Rational vaccine design
Understanding immunity generated by smallpox vaccine may hold lessons for COVID-19 vaccine development. Read MoreSep 22, 2020
-
Throwing weight around on the internet
What users mention in online weight loss forum tracks with how much weight they lose. Read MoreSep 21, 2020
-
Study identifies antibodies that block alphaviruses
Researchers at Vanderbilt University Medical Center have identified antibodies that, in animals, block infection by alphaviruses, which can cause chronic and debilitating joint pain and arthritis and are an increasing global health concern. Read MoreSep 20, 2020
-
VUMC awarded $34 million to lead nationwide convalescent plasma study
Vanderbilt University Medical Center has been awarded a one-year, $34-million grant by the National Center for Advancing Translational Sciences, part of the National Institutes of Health, to conduct a nationwide study of “convalescent plasma” as a treatment for COVID-19. Read MoreSep 20, 2020
-
‘Scavenger’ molecule may point to new atherosclerosis treatment
A small-molecule “scavenger” that reduces inflammation and formation of atherosclerotic plaque in blood vessels in mice potentially could lead to a new approach for treating atherosclerosis in humans, according to researchers at Vanderbilt University Medical Center. Read MoreSep 20, 2020
-
Probing pathogen antibiotic resistance
Understanding how bacteria evolve resistance to antibiotics and host stresses could guide the development of more effective antimicrobial therapeutics. Read MoreSep 17, 2020
-
New predictors of prostate cancer risk
An international group of researchers including Vanderbilt epidemiologists has identified new DNA methylation biomarkers associated with prostate cancer risk. Read MoreSep 17, 2020
-
Sin3a regulates pancreatic β-cells fitness and function
The transcriptional coregulator Swi-independent 3 — or Sin3 — switches on and off the genes that drive crucial biological processes during prenatal development, including cellular differentiation, maturation, survival, metabolism, and stress responses. Read MoreSep 14, 2020
-
Myosin motors regulate cell shape during division
When a bouncy ball deforms under the weight of your body, its rubber membrane stretches and contracts. Likewise, the membrane of a cell doubling itself prior to division must accommodate changes in intracellular pressure — or explode. Read MoreSep 14, 2020
-
VIR-CLASP reveals new insights into cellular mechanisms of viral immune response
RNA viruses invade cells and co-opt cellular machinery to replicate and translate their genomic material. Read MoreSep 10, 2020